Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase

被引:19
|
作者
Li, Q [1 ]
Kasten-Jolly, J
Yen, Y
Freed, BM
机构
[1] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Surg, Albany, NY 12208 USA
[3] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA 91010 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[5] Univ Colorado, Hlth Sci Ctr, Clin Immunol & Histocompatibil Lab, Dept Med, Denver, CO 80262 USA
关键词
D O I
10.1006/taap.1998.8394
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hydroquinone (HQ) is a benzene derivative that is found in large quantities in cigarette tar as a result of the pyrolysis of tobacco flavinoids, HQ is a potent inhibitor of T cell proliferation causing an immediate and complete cessation of DNA synthesis in IL-2-dependent human T lymphoblasts and Jurkat T cells without loss of cell viability. Previous studies from our laboratory demonstrated that the antiproliferative effects of HQ could be partially reversed by the addition of deoxyribonucleosides, but not by the corresponding ribonucleosides, suggesting that HQ might inhibit ribonucleotide reductase, In the present study, the molecular mechanism behind this observation was further investigated. Jurkat T cells were stably transfected with a pMEP4 expression vector containing the gene for the M2 subunit of ribonucleotide reductase under transcriptional control of the human metallothionein IIA promoter. M2-transfected Jurkat T cells exhibited a greater than three-fold increase in resistance to HQ compared to untransfected cells or cells transfected with the M2 gene in the reverse orientation. HQ resistance was associated with an increased level of M2 protein detected by Western blot, These results suggest that the benzene derivative inhibits lymphocyte proliferation by inhibiting ribonucleotide reductase. (C) 1998 Academic Press.
引用
收藏
页码:154 / 157
页数:4
相关论文
共 50 条
  • [41] Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
    Zhang, Hang
    Liu, Xiyong
    Warden, Charles D.
    Huang, Yasheng
    Loera, Sofia
    Xue, Lijun
    Zhang, Suzhan
    Chu, Peiguo
    Zheng, Shu
    Yen, Yun
    BMC CANCER, 2014, 14
  • [42] Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas
    Takao Itoi
    Atsushi Sofuni
    Noriyoshi Fukushima
    Fumihide Itokawa
    Takayoshi Tsuchiya
    Toshio Kurihara
    Fuminori Moriyasu
    Akihiko Tsuchida
    Kazuhiko Kasuya
    Journal of Gastroenterology, 2007, 42
  • [43] Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production
    Perrault, Ella N.
    Shireman, Jack M.
    Ali, Eunus S.
    Lin, Peiyu
    Preddy, Isabelle
    Park, Cheol
    Budhiraja, Shreya
    Baisiwala, Shivani
    Dixit, Karan
    James, C. David
    Heiland, Dieter H.
    Ben-Sahra, Issam
    Pott, Sebastian
    Basu, Anindita
    Miska, Jason
    Ahmed, Atique U.
    SCIENCE ADVANCES, 2023, 9 (20)
  • [44] Ribonucleotide reductase subunit M2 mRNA expression in pretreatment biopsies obtained from unresectable pancreatic carcinomas
    Itoi, Takao
    Sofuni, Atsushi
    Fukushima, Noriyoshi
    Itokawa, Fumihide
    Tsuchiya, Takayoshi
    Kurihara, Toshio
    Moriyasu, Fuminori
    Tsuchida, Akihiko
    Kasuya, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY, 2007, 42 (05) : 389 - 394
  • [45] Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
    Zhou B.-S.
    Tsai P.
    Ker R.
    Tsai J.
    Ho R.
    Yu J.
    Shih J.
    Yen Y.
    Clinical & Experimental Metastasis, 1998, 16 (1) : 43 - 49
  • [46] Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
    Zhou, BS
    Tsai, P
    Ker, R
    Tsai, J
    Ho, R
    Yu, J
    Shih, J
    Yen, Y
    CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (01) : 43 - 49
  • [47] SUBUNIT M2 OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE - CHARACTERIZATION OF A HOMOGENEOUS PROTEIN ISOLATED FROM M2-OVERPRODUCING MOUSE CELLS
    THELANDER, M
    GRASLUND, A
    THELANDER, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1985, 260 (05) : 2737 - 2741
  • [48] Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers
    Hang Zhang
    Xiyong Liu
    Charles D Warden
    Yasheng Huang
    Sofia Loera
    Lijun Xue
    Suzhan Zhang
    Peiguo Chu
    Shu Zheng
    Yun Yen
    BMC Cancer, 14
  • [49] THE ONCOGENIC POTENTIAL OF RIBONUCLEOTIDE REDUCTASE M2 (RRM2) IN CLEAR CELL RENAL CELL CARCINOMA
    Abudawood, Manal
    Ahmed, Nessar
    Wang, Qiuyu
    ANTICANCER RESEARCH, 2014, 34 (10) : 6239 - 6240
  • [50] Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma
    Iwamoto, Kazuki
    Nakashiro, Koh-Ichi
    Tanaka, Hiroshi
    Tokuzen, Norihiko
    Hamakawa, Hiroyuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (05) : 1971 - 1977